Communiqués Ventas, Inc. London S.E.

Actions

0LO4

US92276F1003

Sociétés de placement immobilier spécialisé

Marché Fermé - London S.E. Autres places de cotation 15:44:04 15/04/2025			Varia. 5j.	Varia. 1 janv.
67,56 ^USD	+47,29%		-32,47%	-12,65%

30/07	VENTAS, INC. : BNP Paribas favorable sur le dossier	ZM
30/07	Transcript : Ventas, Inc., Q2 2026 Earnings Call, Jul 30, 2026

Communiqués

29/07	Ventas: Q2 Earnings Snapshot	AQ
29/07	Ventas Reports 2026 Second Quarter Results	BU
29/06	Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call	BU
22/06	Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research	BU
03/06	Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement	BU
01/06	Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit’s REITweek 2026 Investor Conference	BU
13/05	Ventas Declares Quarterly Dividend of $0.52 Per Common Share	BU
27/04	Ventas: Q1 Earnings Snapshot	AQ
27/04	Ventas : First Quarter 2026 Press Release	PU
27/04	Ventas : First Quarter 2026 Supplemental Report	PU
27/04	Ventas Reports 2026 First Quarter Results	BU
02/04	Ventas Announces First Quarter 2026 Earnings Release Date and Conference Call	BU
02/03	Ventas Issues Investor Presentation for Upcoming Investor Conferences	BU
05/02	Ventas: Q4 Earnings Snapshot	AQ
05/02	Ventas : Fourth Quarter 2025 Supplemental Report	PU
05/02	Ventas Reports Fourth Quarter and Full Year 2025 Results, Provides 2026 Outlook and Increases Dividend	BU
21/01	Ventas Announces Tax Treatment of 2025 Distributions	BU
14/01	Ventas Announces Fourth Quarter 2025 Earnings Release Date and Conference Call	BU
10/12	Ventas Declares Quarterly Dividend of $0.48 Per Common Share	BU
09/12	Ventas : 2025 Nareit REITworld Conference	PU
05/12	Ventas to Participate in Investor Meetings at Nareit’s REITworld 2025 Annual Conference	BU
02/12	Ventas Announces Pricing of Senior Notes Offering	BU
18/11	Ventas Announces Planned Retirement of Peter J. Bulgarelli, EVP, Outpatient Medical and Research and CEO of Lillibridge Healthcare Services	AQ
17/11	Ventas Announces Planned Retirement of Peter J. Bulgarelli, EVP, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services	BU
29/10/25	Ventas : Third Quarter 2025 Supplemental Report	PU